{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:47:33Z","timestamp":1790617653521,"version":"4.1.0"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,25]]},"DOI":"10.7759\/cureus.67751","type":"journal-article","created":{"date-parts":[[2024,8,25]],"date-time":"2024-08-25T22:13:36Z","timestamp":1724624016000},"source":"Crossref","is-referenced-by-count":5,"title":["Diffuse Facial Leukoderma Secondary to Localized Use of Hydroquinone"],"prefix":"10.7759","author":[{"given":"Christina","family":"Artz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mavra","family":"Masood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasneem F","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-024-02990-6","article-title":"An update on the safety of hydroquinone","volume":"316","author":"Shivaram K","year":"2024","unstructured":"Shivaram K, Edwards K, Mohammad TF. An update on the safety of hydroquinone. Arch Dermatol Res. 2024, 316:378. 10.1007\/s00403-024-02990-6","journal-title":"Arch Dermatol Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/01.DER.0000438425.56740.8a","article-title":"Hydroquinone-induced depigmentation: case report and review of the literature","volume":"25","author":"Jow T","year":"2014","unstructured":"Jow T, Hantash BM. Hydroquinone-induced depigmentation: case report and review of the literature. Dermatitis. 2014, 25:e1-e5. 10.1097\/01.DER.0000438425.56740.8a","journal-title":"Dermatitis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3109\/09546630903341945","article-title":"Hydroquinone for skin lightening: safety profile, duration of use and when should we stop?","volume":"21","author":"Tse TW","year":"2010","unstructured":"Tse TW. Hydroquinone for skin lightening: safety profile, duration of use and when should we stop?. J Dermatolog Treat. 2010, 21:272-275. 10.3109\/09546630903341945","journal-title":"J Dermatolog Treat"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/ijdvl.IJDVL_209_17","article-title":"Chemical leukoderma due to hydroquinone: an unusual phenomenon","volume":"85","author":"Das A","year":"2019","unstructured":"Das A, Ghosh A, Kumar P. Chemical leukoderma due to hydroquinone: an unusual phenomenon. Indian J Dermatol Venereol Leprol. 2019, 85:567. 10.4103\/ijdvl.IJDVL_209_17","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2994","article-title":"Disfiguring leukoderma caused by banned cosmetics: a quiz","volume":"98","author":"Atzori L","year":"2018","unstructured":"Atzori L, Zanniello R, Sarais G, et al.. Disfiguring leukoderma caused by banned cosmetics: a quiz. Acta Derm Venereol. 2018, 98:914-915. 10.2340\/00015555-2994","journal-title":"Acta Derm Venereol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1982.tb04219.x","article-title":"Leukoderma from bleaching creams containing 2% hydroquinone","volume":"8","author":"Fisher AA","year":"1982","unstructured":"Fisher AA. Leukoderma from bleaching creams containing 2% hydroquinone. Contact Dermat. 1982, 8:272-273. 10.1111\/j.1600-0536.1982.tb04219.x","journal-title":"Contact Dermat"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1396-0296.2004.04015.x","article-title":"Management of dyschromias in ethnic skin","volume":"17","author":"Halder RM","year":"2004","unstructured":"Halder RM, Richards GM. Management of dyschromias in ethnic skin. Dermatol Ther. 2004, 17:151-157. 10.1111\/j.1396-0296.2004.04015.x","journal-title":"Dermatol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/257959-diffuse-facial-leukoderma-secondary-to-localized-use-of-hydroquinone","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,25]],"date-time":"2024-08-25T22:13:41Z","timestamp":1724624021000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/257959-diffuse-facial-leukoderma-secondary-to-localized-use-of-hydroquinone"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,25]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.67751","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,25]]}}}